About this trial
The study will investigate the use of Electroencephalography (EEG) in understanding mild cognitive impairment (MCI). EEG is commonly used in everyday clinical practice for the assessment of a wide range of neurological disorders. It records the brains spontaneous electrical signals and offers a non-invasive means of visually evaluating brain signals. By analysing these signals, we aim to uncover invaluable insights into cognitive impairments and the ageing brains cognitive processes.
Eligibility criteria
Qualifiers
Diagnosed with mild cognitive impairments (MCI) or mild dementia
Normal or corrected-to-normal vision
Can maintain sitting with or without support for around 60 minutes continuously
Cognitive and language abilities to understand and participate in the study protocol and able to give consent and understand instructions
Disqualifiers
Severe cognitive impairment that would interfere with their ability to comply with the experimental protocol or provide informed consent
Pre-existing severe systemic disorders like active cancer, end-stage pulmonary or cardiovascular disease, psychiatric illness including severe alcohol or drug abuse
Past history of epilepsy- with seizures in last 12 months
History of photosensitive epilepsy.
Trial design
Treatments tested in this trial
- MoCA Test
- Random Dot Motion (RDM) task
- P300-BCI task without feedback